Reaction
Bladder Operation reporting signals
As of the last recalculation, Bladder Operation appears in 1,149 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is TOLTERODINE TARTRATE (PRR 16.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tolterodine Tartrate | 8 | 16.3 | 16.3 |
| Oxybutynin Chloride | 7 | 14.5 | 14.6 |
| Vibegron | 6 | 13.6 | 13.6 |
| Mirabegron | 25 | 11.9 | 11.9 |
| Fesoterodine Fumarate | 6 | 10.1 | 10.1 |
| Ibrutinib | 42 | 9.7 | 9.7 |
| Upadacitinib | 36 | 8.2 | 8.2 |
| Relugolix | 10 | 7.7 | 7.7 |
| Risankizumab-Rzaa | 34 | 7.7 | 7.7 |
| Abiraterone | 5 | 6.7 | 6.7 |
| Avapritinib | 3 | 4.5 | 4.5 |
| Rimegepant Sulfate | 3 | 4.3 | 4.3 |